Galenica AG engages in the provision of health care. The company is headquartered in Bern, Bern and currently employs 6,125 full-time employees. The company went IPO on 2017-04-07. The firm's business i divided into three business sectors: Retail, Products & Brands, and Services. The firm manages a locally established pharmacies network in Switzerland. The company develops and distributes its own product portfolio, as well as cooperates with a range of business partners, such as Pierre Fabre, Ales Groupe and Vitor Consumer Health for marketing and distribution of such brands as Perskindol, Triofan, A-Derma, Lierac, Phyto, Anti-Brumm and Algifor. Galenica Sante's Services business sector is responsible for management of such logistics sector companies as Galexis, Unione Farmaceutica Distribuzione, Alloga and Medifilm.
Quelle est la performance du prix de l'action GALENICA AG ?
Le prix actuel de GALENICA AG est de $0, il a diminué de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Galenica AG ?
Galenica AG appartient à l'industrie Health Care et le secteur est Health Care
Quel est la capitalisation boursière de Galenica AG ?
La capitalisation boursière actuelle de Galenica AG est de $NaN
Est-ce que Galenica AG est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 7 analystes ont établi des notations d'analystes pour Galenica AG, y compris 0 achat fort, 0 achat, 6 maintien, 4 vente et 0 vente forte